Michele Peiretti - Concepedia

Author

Michele Peiretti

European Institute of Oncology ORCID

Also Known As

M Peiretti, M. Peiretti, Michele Peiretti, Peiretti M, Peiretti Michele

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

European Institute of Oncology University of Cagliari Kliniken Essen-Mitte University of Milano-Bicocca Fondazione IRCCS Istituto Nazionale dei Tumori

About

Michele Peiretti is an author at European Institute of Oncology specializing in obstetrics, medicine, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	1.8K
2	Public Health	6	6	499
3	Gastroenterology	1	1	86
4	Neurology	1	1	12
5	Nutrition	1	1	86

Michele Peiretti

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Nicoletta Colombo, Michele Peiretti, Annalisa Garbi, Annals of Oncology Tumoral PathologyGynecological SurgeryMedicineCancer ManagementGynecology	2012	287
Management of recurrent cervical cancer: A review of the literature Michele Peiretti, Ignacio Zapardiel, Vanna Zanagnolo, Surgical Oncology	2012	185
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Nicoletta Colombo, Michele Peiretti, Gabriella Parma, Annals of Oncology Gynecological SurgeryMedicineCancer ManagementEpithelial Ovarian CarcinomaGynecology	2010	180
Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan Angelo Maggioni, Giovanni Roviglione, Fabio Landoni, Gynecologic Oncology LaparoscopySurgical OncologyCervical CancerEuropean InstituteMedicine	2009	161
Robotic approach for cervical cancer: Comparison with laparotomy A case control study Angelo Maggioni, Lucas Minig, Vanna Zanagnolo, Gynecologic Oncology Robotic ApproachSurgical OncologyCervical CancerComputer-assisted SurgeryMedicine	2009	129
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study Andrea Alberto Lissoni, Nicoletta Colombo, Antonio Pellegrino, Annals of Oncology Surgical OncologyCervical Cancer ManagementCervical CancerPhase IiMedicine	2009	122
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience Michele Peiretti, Vanna Zanagnolo, Giovanni Aletti, Gynecologic Oncology Oncological OutcomesGynecologic SurgerySurgical OncologySingle Institution ExperienceGynecological Surgery	2010	106
Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome Maria Teresa Sandri, Fabio Bottari, D. Franchi, Gynecologic Oncology InfertilityGynecological SurgeryCervical CancerPelvic ProlapsePelvic Mass	2012	104
Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes Michele Peiretti, Robert E. Bristow, Ignacio Zapardiel, Gynecologic Oncology Surgical OncologyGynecological SurgeryAdvanced Ovarian CancerColorectal SurgeryMedicine	2012	94
Early Oral Versus “Traditional” Postoperative Feeding in Gynecologic Oncology Patients Undergoing Intestinal Resection: a Randomized Controlled Trial Lucas Minig, R. Biffi, Vanna Zanagnolo, Annals of Surgical Oncology NutritionGynecologic SurgerySurgical OncologyGastroenterologyGynecology	2009	86

Page 1